Invention Grant
- Patent Title: Deuterated pentylenetetrazoles for improving cognitive function
-
Application No.: US15246347Application Date: 2016-08-24
-
Publication No.: US09951076B2Publication Date: 2018-04-24
- Inventor: Lyndon Lien
- Applicant: Balance Therapeutics, Inc.
- Applicant Address: US CA Hillsborough
- Assignee: Balance Therapeutics, Inc.
- Current Assignee: Balance Therapeutics, Inc.
- Current Assignee Address: US CA Hillsborough
- Agency: Jones Day
- Main IPC: C07D487/04
- IPC: C07D487/04 ; C07B59/00

Abstract:
Provided are compounds having formula I: wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 are as disclosed herein, or a pharmaceutically salt thereof. Pharmaceutical compositions comprising the compounds and methods of their use, for instance in treating senility, senile confusion, psychoses, psychoneuroses when anxiety and nervous tension were present, cerebral arteriosclerosis, nausea, depression, fatigue, debilitation, mild behavioral disorders, irritability, emotional instability, antisocial attitudes, anxiety, vertigo or incontinence, or symptom thereof, or in improving cognitive function in individuals, for instance, in individuals with Down syndrome and other conditions, are also provided.
Public/Granted literature
- US20170044165A1 PENTYLENETETRAZOLE DERIVATIVES Public/Granted day:2017-02-16
Information query